UNITED NEWS INTERNATIONAL (UNI) — The U.S. Food and Drug Administration has approved the first gene therapy in the country.
Experts developed the treatment to combat a certain form of cancer.
The FDA announced the treatment’s approval on Twitter, Aug. 30.
The treatment, called Kymriah, is approved for child and young adult patients up to 25 years old with a certain form of acute lymphoblastic leukemia, or ALL.
According to the National Cancer Institute, ALL is the most common form of cancer among children.
The FDA said the new treatment involves genetically modifying a patient’s white blood cells in a lab and reintroducing them to the patient to better combat the disease.
FDA Commissioner Scott Gottlieb said, “We’re entering a new frontier in medical innovation with the ability to reprogram a patient’s own cells to attack a deadly cancer.”
Gottlieb said this new approach has the potential to transform medicine.